Correction: Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial

• Martin Bergman,
• Namita Tundia,
• Naomi Martin,
• Jessica L. Suboticki,
• Jayeshkumar Patel,
• Debbie Goldschmidt,
• Yan Song,
• Grace C. Wright

Affiliations

Martin Bergman

Drexel University College of Medicine

Namita Tundia

AbbVie Inc

Naomi Martin

AbbVie Inc

Jessica L. Suboticki

AbbVie Inc

Jayeshkumar Patel

AbbVie Inc

Debbie Goldschmidt

Analysis Group, Inc

Yan Song

Analysis Group, Inc

Grace C. Wright

Grace C Wright MD PC; Association of Women in Rheumatology; United Rheumatology